Gene: SYT15
Official Full Name: synaptotagmin 15provided by HGNC
Gene Summary: This gene encodes a member of the Synaptotagmin (Syt) family of membrane trafficking proteins. Members of this family contain a transmembrane region and a C-terminal-type tandem C2 domain. Unlike related family members, the encoded protein may be involved in membrane trafficking in non-neuronal tissues. Two trancript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25365 | SYT15 Knockout cell line (HEK293) | Human | SYT15 | 1:3~1:6 | Negative | Online Inquiry |
SYT15 Gene Knockout Cell Lines are sophisticated research tools designed to facilitate the study of gene function and cellular mechanisms by enabling researchers to investigate the effects of gene disruption. These cell lines have been genetically modified to eliminate the expression of the SYT15 gene, a crucial element implicated in various cellular processes, including synaptic transmission and cellular signaling pathways. By providing a model system in which the normal function of this gene is absent, scientists can assess the resultant phenotypic changes, thus gaining insights into the underlying biological mechanisms.
The primary function of the SYT15 Gene Knockout Cell Lines is to enable the exploration of SYT15’s role in cellular dynamics and disease states. Utilizing CRISPR/Cas9 gene-editing technology, these cell lines exhibit a high degree of specificity and efficiency in knockout generation, ensuring that researchers are working with precise models. This allows for robust experimental designs, including functional assays, drug response studies, and pathways analysis that contribute to the burgeoning field of gene therapy and precision medicine.
The scientific importance of SYT15 Gene Knockout Cell Lines cannot be overstated, particularly in research and clinical settings focused on neurological diseases and conditions characterized by impaired synaptic functions. These models are invaluable for delineating the genetic and cellular etiology of such diseases, paving the way for the development of targeted therapies. Furthermore, the ability to conduct high-throughput screening of small molecules or genetic interventions in these knockout lines accelerates the pace of discovery.
Unlike alternative gene knockout models, which may suffer from off-target effects or variability in expression, our SYT15 Gene Knockout Cell Lines offer consistency and reliability for reproducible results. Researchers benefit from established protocols and high-quality control measures that ensure the integrity and performance of these cell lines, enhancing experimental outcomes.
In a landscape where precise genetic tools are essential for advancement, SYT15 Gene Knockout Cell Lines present an unparalleled opportunity for researchers and clinicians to deepen their understanding of SYT15-related mechanisms and explore innovative treatment strategies. Our company, with its strong foundation in genetic engineering and commitment to supporting scientific discovery, is dedicated to delivering high-quality biological products that empower the next generation of research and therapy.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.